Short-term Pre-OPerative Durvalumab (MEDI 4736) in early small triple negative breast cancer patients (POP-Durva)

2024-512082-14-00 Protocol CSET n° 2020/3210 Therapeutic exploratory (Phase II) Ongoing, recruiting

Start 6 Dec 2021 · Status Ongoing, recruiting · 1 EU/EEA countries · 4 sites · Protocol CSET n° 2020/3210

Overview

Sponsor-declared trial summary

Phase Therapeutic exploratory (Phase II)
Status Ongoing, recruiting
Participants planned 100
Countries 1
Sites 4

Untreated small triple negative breast cancer

Key facts

Sponsor
Institut Gustave Roussy
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Female
Therapeutic area
Diseases [C] - Pathological Conditions, Signs and Symptoms [C23], Diseases [C] - Immune System Diseases [C20]
Trial duration
6 Dec 2021 → ongoing
Decision date (initial)
2024-04-26
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

External identifiers

EU CT number
2024-512082-14-00
EudraCT number
2020-006106-23

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Untreated small triple negative breast cancer

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Institut Gustave Roussy

Sponsor organisation
Institut Gustave Roussy
Address
114 Rue Edouard Vaillant
City
Villejuif
Postcode
94800
Country
France

Scientific contact point

Organisation
Institut Gustave Roussy
Contact name
Dr Joana M Ribeiro

Public contact point

Organisation
Institut Gustave Roussy
Contact name
Dr Joana M Ribeiro

Locations

1 EU/EEA country · 4 investigational sites

By country

CountryMS statusPlanned subjectsSites
France Ongoing, recruiting 100 4
Rest of world 0

Investigational sites

France

4 sites · Ongoing, recruiting
Institut Bergonie
ONCOLOGIE, 180 R De Saint Genes, 229 Cours De L Argonne, Bordeaux
Centre Leon Berard
ONCOLOGIE, 28 Rue Laennec, 69008, Lyon
Institut Gustave Roussy
ONCOLOGIE, 114 Rue Edouard Vaillant, 94800, Villejuif
Centre Jean Perrin
ONCOLOGIE, 58 Rue Montalembert, 63000, Clermont-Ferrand

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
France 2021-12-06 2024-04-26

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-04-12 France Acceptable
2024-04-26
2024-04-26